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ABSTRACT 
 
Purpose 
A recently identified colistin resistance gene, mcr-1, has been reported in many countries. In this study, 
we established a new real-time PCR method to detect it.  
 
Methodology 
We used a real-time PCR method to detect the mcr-1 gene in a variety of isolates and faecal samples from 
20 provinces and municipal cities in China. 
 
Results 
Of the 2330 isolates (from 10 species) screened, 54 (2.3 %) isolates were positive for mcr-1. All of the 
mcr-1-positive isolates that were identified belonged to Escherichia coli strains, among which 9, 1, and 44 
were identified as enteropathogenic E. coli, enteroadherent E. coli, and non-pathogenic E. coli, 
respectively. The majority of the mcr-1-positive isolates were obtained from farm animals from eight 
provinces and municipal cities across China. A total of 337 faecal samples, including 229 human and 108 
pet animal faecal samples, were also screened for the mcr-1 gene. Of the 337 samples analyzed, six and 
eight human and pet animal faecal samples were positive for the mcr-1 gene, respectively.   
 
Conclusion 
The data demonstrate that the mcr-1 gene is highly prevalent in human and animal populations in China. 
This occurrence suggests that active surveillance of the mcr-1 gene is imperative in curtailing its spread 
 
 
INTRODUCTION 
 
Antimicrobial resistance is considered one of the most urgent public health problems of the twenty-first 
century. The phenomenon of antibiotic resistance threatens to affect human health worldwide. This 
problem has intensified following the emergence of carbapenem-resistant strains of Enterobacteriaceae, 
leaving colistin as one of the few remaining clinical treatment options for the treatment of infections which 
caused by carbapenem-resistant strains of Enterobacteriaceae. However, colistin is also widely used to treat 
infected animals, especially in China [ 1, 2 ]. 
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In 2016, Liu and colleagues reported a plasmid-mediated colistin-resistance (designated mcr-1) gene in 
China. The mcr-1 gene encodes a lipid A phosphoethanolamine transferase that is capable of inactivating 
colistin [ 1 ]. It has subsequently been found that the mcr-1 gene is not only carried by different plasmids, 
but also located on the chromosome [ 1, 3–8 ]. Several MCR-1-positive Enterobacteriaceae have been 
isolated from both humans and animals in many different countries. These observations suggest that 
the mcr-1 gene has been disseminated globally and is likely to impact both clinical and animal husbandry 
treatment strategies [ 9–13 ]. Thus, active surveillance pertaining to mcr-1 gene dissemination is of 
paramount importance. 
In this study, a novel real-time PCR assay was developed and used to detect the mcr-1 gene in a variety of 
isolates from human and pet faecal samples in China. 
 
METHODS 
 
Isolates and faecal samples 
A total of 2330 Gram-negative isolates were investigated in this study. These isolates from 20 provinces 
and municipal cities in China were obtained between 1998 and 2015. The species pertaining to these 
Gram-negative isolates are listed in Table 1 , and the geographical distribution details are presented 
in Figure 1 . Detailed information relating to isolate screening is shown in Table 2 . The number of 
isolates obtained during the years 2010 to 2015 ( n=2014) was much more than the number of isolates 
obtained before 2010 ( n=316). The pathogenic Escherichia coli isolates were identified by virulence 
gene PCR-typing and serotyping as done in a previous study [ 14 ]. Most of the isolates were collected from 
human faeces (from diarrhoea patients and healthy humans), poultry faeces (from broilers) and livestock 
faeces (from swine, cattle, goats and mutton sheep). A small proportion of the isolates were from 
commercially available food (from vegetables, chicken, pork, beef, meat stuffing, cured meat and animal 
innards), insects (from dung beetles and flies), fowl faeces (from egrets and pigeons), rodent intestinal 
contents (from pikas and marmots) and environmental samples (from fences and water in swine farms). 
The top three areas in respect of the number of isolates that were collected were Shandong, Henan and 
Beijing. 
A total of 337 faecal samples were collected from Beijing and Hainan provinces between 2014 and 2015. 
Among these, 229 (159 and 70 samples from Beijing and Hainan, respectively) were obtained from 
humans and 108 (from a single Beijing animal hospital) were obtained from pet animals (77 from dogs 
and 31 from cats). 
 
DNA extraction 
DNA from bacterial isolates and standard strains was extracted using a commercial DNA extraction kit 
(TIANGEN TIANamp Bacteria DNA kit; TIANGEN BIOTECH). DNA from faecal samples was 
extracted using a commercial QIAamp stool extraction kit (QIAGEN). All of the extracted DNA 
templates were stored at −20ௗ°C until further required. 
Real-time PCR primers, fluorescence probe for mcr-1 gene and real-time PCR assay 
Real-time PCR primers and minor groove binder (MGB)-conjugated fluorescent probes were designed to 
amplify a 102 base pair DNA fragment (positions 143 to 244) from the mcr-1 coding region (GenBank 
no. KP347127). The forward primer (5′-TCG GCT TTG TGC TGA CGA T-3′), the reverse primer (5′-
AAA TCA ACA CAG GCT TTA GCA CAT A-3′) and the 6-carboxyfluorescein (FAM)-labelled mcr-1-
specific probe (5′-FAM-CTG TCG TGC TCT TTG-MGB-3′) used in this study were procured from 
Shanghai GeneCore Biotechnologies. The LightCycler 480 II (Roche Diagnostics) was used for the 
amplification and detection of the mcr-1 gene. Each PCR run included a negative control, an 
external mcr-1-positive control and an internal processing control (16S rDNA locus). The amplification 
conditions were 95ௗ°C for 180 s followed by 40 quantitative cycles of 95ௗ°C for 5 s, 58ௗ°C for 20 s and 
40ௗ°C for 20 s. 
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Construction of the recombinant plasmid carrying the mcr-1 gene 
The pEASY-T5 Zero Cloning kit (TRANSGEN BIOTECH) was used to generate a plasmid harbouring 
the mcr-1 gene-specific fragment (using the primers described above and a whole mcr-1 gene-carrying 
plasmid) to measure copy number. The number of mcr-1 gene plasmid copies was calculated using the 
value for the plasmid molecular weight and the following formula: 
Standard plasmid copies μl-1) 
= Standard plasmid concentration (μg μl-1) x Avogadro’s number x 10-9 
660 x Number of recombinant plasmid base pairs 
 
The PCR LightCycler 480 Probes Master kit (Roche Diagnostics) was used to generate standard plasmid 
serial dilutions, and nine concentration gradients from 1.0×10 0 to 1.0×10 8 copies µl −1 of standard 
plasmids were generated. Concentration gradient generation was performed in triplicate for standard 
curve construction and sensitivity evaluation. 
Simulated faecal samples and mcr-1 detection evaluation 
An E. coli strain containing a whole mcr-1 gene-carrying plasmid was used as a control and cultured 
overnight in brain–heart infusion broth until the culture reached an OD 600 of 0.6. A plate-counting assay 
confirmed that the culture contained 2.2×10 8 c.f.u. ml −1. Nine concentration gradients from 1.1×10 0 to 
1.1×10 8 c.f.u. ml −1 were generated by serial dilution. These dilutions were added to healthy human faeces 
to generate simulated mcr-1-positive faecal samples. DNA from faecal samples was extracted as 
described above. 
Determination of specificity of the mcr-1 PCR method 
Escherichia coli strain ATCC 25922, Acinetobacter lwoffi strain ATCC 15309 and Pseudomonas 
aeruginosa strain ATCC 27853 do not harbour themcr-1 gene and were used as negative control strains. 
Genomic DNA extracted from these strains was used to evaluate the specificity of themcr-1 gene PCR 
method. 
 
RESULTS 
 
Sensitivity and specificity of the mcr-1 gene PCR assay 
A recombinant plasmid containing the mcr-1 gene was serially diluted to generate nine concentration 
gradients (from 1.0×10 0 to 1.0×10 8copies µl −1) to determine the limit of detection by copy number. The 
detection limit of this mcr-1 gene PCR method was determined to be 1.0×10 1 copies per reaction, and 
a C t value of less than 35 was considered as mcr-1-positive for the sample tested. 
We next determined the detection limit for the assay by colony counting using the simulated faecal 
sample. This sample was diluted to between 1.1×10 3 and 1.1×10 8 c.f.u. ml −1 mcr-1 positive E. coli. The 
limit of mcr-1 detection by PCR was 1.1×10 3 c.f.u. ml −1, and a C t value of less than 35 was considered 
as mcr-1-positive. We did not perform dilutions lower than 1.1×10 3 c.f.u. ml −1; thus, the detection limit 
may be even lower. 
To evaluate the specificity of the assay, an mcr-1 recombinant plasmid was used as positive control. The 
three negative control strains, E. coliATCC 25922, A. lwofii ATCC 15309 and P. aeruginosa ATCC 
27853, did not produce a positive signal. 
Screening of mcr-1 in a large collection of isolates from different species 
A total of 2330 isolates were screened using the newly established PCR method. The isolates were 
obtained from 20 different geographical regions and consisted of both human and farm animal isolates 
(see Table 2 ). Fifty-four of the tested isolates (2.3௘%) were positive for the mcr-1 gene (see Table 3 ). 
Interestingly, all of the 54 mcr-1-positive strains were E. coli (54/1709, 3.2ௗ%) including one (1/128, 
0.8ௗ%) enteroaggregative E. coli (EAEC) isolate, nine (9/402, 2.2ௗ%) enteropathogenic E. coli (EPEC) 
isolates and 44 (44/697, 6.3ௗ%) nonpathogenic E. coli isolates. The pathogenic E. coli isolates were 
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obtained from a variety of sources (diarrhoea patients, healthy human, commercially food, livestock or 
poultry), and the nonpathogenic E. coli isolates were from farm environment, livestock and poultry faeces 
(For details, see Table 3). The mcr-1-positive isolates were obtained from human faeces (3/1161, 0.3ௗ%), 
livestock and poultry faeces (45/981, 4.6ௗ%), food (4/103, 3.9ௗ%) and environmental samples (2/9, 
22.2ௗ%) between 2010 and 2014. The oldest isolate was obtained from a faecal livestock sample in 
Xinjiang province in 2010, and the majority of mcr-1-positive isolates were from farm animals in 
Xinjiang (30 isolates, four from goat faeces in 2010, one from swine faeces in 2010, one from cattle 
faeces in 2012 and 24 from swine faeces in 2013) and Shandong province (12 isolates, all from poultry 
faeces). 
 
Screening of mcr-1 gene in human and pet animal faecal samples 
A total of 337 faecal samples (229 from hospital inpatients and 108 from pet animals) were screened 
for mcr-1. Fourteen samples (4.2ௗ%) weremcr-1-positive ( Table 4 ). The positive rate was lower in 
inpatient samples than pet samples with six (2.6ௗ%) positive inpatient faecal samples and eight (7.4ௗ%) 
positive pet animal faecal samples identified, respectively. None of the 159 human faecal samples from 
Beijing was mcr-1-positive while six of the 70 (8.6ௗ%) human faecal samples from Hainan were mcr-1-
positive. 
 
DISCUSSION 
 
Sensitivity and specificity of the mcr-1 PCR assay 
The mcr-1 gene was a new polymyxin resistance gene that was described last year [ 1 ]. In this study, a 
new PCR method was developed to detect mcr-1. The detection limit of the mcr-1 gene, which was 
determined using a plasmid standard curve analysis and simulated faecal sample detection, was 
1.0×10 1 copies per reaction system and 1.1×10 3 c.f.u. ml −1, respectively. None of the mcr-1 negative 
strains resulted in the generation of an amplification curve. Thus, the new mcr-1 gene PCR method 
developed in this study displayed high sensitivity and specificity. This method is simple and rapid, and 
can be used for mcr-1 detection in clinical, animal husbandry and food samples. From screening a large 
collection of isolates, human and pet animal faecal samples, we demonstrated that this PCR method is 
effective for direct detection of the mcr-1 gene from faecal specimens. 
Dissemination of the mcr-1 gene throughout China 
Liu and colleagues have reported that a plasmid-mediated colistin resistance gene, mcr-1, can be carried 
by E. coli and Klebsiella pneumoniaeisolates from animals and inpatients in the south of China [ 1 ]. Our 
study expanded the geographic coverage by investigating whether mcr-1was present in isolates from 19 
new provinces and municipal cities. This study also analysed a variety of sources including faeces from 
livestock, poultry, fowl, rodents and humans, along with food and environmental samples (see Figure 
1 , Table 2 ). A total of 54 out of 2330 isolates and 14 out of 337 faecal samples were identified to 
be mcr-1-positive. We also observed that mcr-1 isolates were present in eight ‘new’ regions of China 
including Xinjiang in the far northwest and Heilongjiang in the far northeast, suggesting that mcr-1 is 
widespread in China ( Figure 1 ). For the mcr-1-positive isolates detected in this study, we found that 
the mcr-1-carrying plasmids were different sizes varying from less than 60 to 150 kb (data not shown), 
suggesting transfer of the mcr-1 gene between plasmids. Liu et al. [ 1 ] showed that the flanking sequences 
of the mcr-1 gene were homologous in some of their isolates, also suggesting transfer of the mcr-1 gene 
between plasmids. Other studies have shown that the mcr-1 gene could be transmitted through 
conjugative plasmids [ 1, 3–6, 15 ]. Further studies will be needed to elucidate the mechanisms of the mcr-
1 gene. 
Up until now, the mcr-1 gene has predominantly been found in Enterobacteriaceae isolates [ 1, 2, 16–21 ], 
especially in E. coli strains. Moreover, all of the mcr-1-positive isolates from this study were E. 
coli strains. Importantly, 10 of the strains isolated between 2011 and 2014 were pathogenic E. coli. Three 
5 
 
of these pathogenic E. coli isolates (one EAEC strain and two EPEC strains) were obtained from humans, 
although colistin is not currently used in the routine treatment of E. coli infections. The presence of mcr-
1-positive pathogenic E. coli isolates in infected patients highlights the potential threat to human health, 
with polymyxins previously representing ‘the last line’ of therapeutic agents to combat multidrug resistant 
Gram-negative infections. 
Previous studies have shown that the prevalence of the mcr-1 gene is lower in E. coli strains of human 
origin compared with strains isolated from animal and food samples [ 1, 10, 15, 18 ]. Our data are consistent 
with these findings. The mcr-1-positive rate in human isolates is 0.3ௗ% (3/1144) while the rate in 
commercial food isolates and in livestock and poultry faecal isolates were 5.6ௗ% (4/72) and 6.3ௗ% 
(45/718), respectively. Overall our rate is lower than those reported by Liu and colleagues, in which 
the mcr-1-positive rate was 1.2ௗ% in humans, 14.9ௗ% in raw meat samples (pork and chicken), and 20.7ௗ% 
in swine [ 1 ]. However, the difference in positive rates may be due to regional difference, sample type 
difference and difference in the years when the isolates were collected. 
In our study, the mcr-1-positive isolates were collected between 2010 and 2014. Most of our mcr-1-
positive strains were isolated in 2013 and the oldest isolate was collected from a Xinjiang province 
livestock faecal sample in 2010. However, the first observation of the mcr-1 isolate in China occurred in 
the 1980s and rapid increase of mcr-1 prevalence in E. coli from poultry was observed from 2011 
onwards [ 2 ]. In the first report of mcr-1 by Liu et al. [ 1 ], the positive rate was also higher in 2012–2014 
isolates, than in 2011 isolates including isolates from pigs at slaughter house and chicken and pork meat. 
All data suggest that mcr-1 prevalence has been rapidly increasing in recent years. 
Direct detection and prevalence of the mcr-1 gene in human and pet animal faecal samples 
in Beijing and Hainan 
In this study, we detected the mcr-1 gene in faecal samples using a PCR method and observed that six 
human and eight pet faecal samples were mcr-1-positive. 
It has been suggested that pets can transmit mcr-1 E. coli [ 22 ]. To the best of our knowledge, our study is 
the first report to show that themcr-1 gene has been directly detected in pet faecal samples. Since pets are 
in direct and frequent contact with humans, it needs to be recognized that pets act as a reservoir for 
colistin-resistant bacteria and are potentially an important source of human infective colistin-resistant 
bacteria. All of the mcr-1-positive human faecal samples were from Hainan while none of the human 
faecal samples from Beijing wasmcr - 1-positive, suggesting that there is a regional difference in its 
prevalence in the human population. However, it could also be due to sampling. Considering that the two 
EPEC isolates from food samples and eight pet faecal samples were mcr-1-positive from Beijing, it is 
likely that mcr-1-positive E. coli is present in the human population in Beijing though it has not been 
sampled in this study. 
In conclusion, we utilized a newly established PCR method to screen a large collection of bacterial 
isolates from more than 10 species. We examined 2330 isolates of different species and found that only E. 
coli isolates carried the mcr-1 gene. The mcr-1-positive rate was 2.3ௗ% for all isolates and 3.2ௗ% for E. 
coli. Screening of pet animal faecal samples from Beijing suggested an mcr-1-positive rate of 7.4ௗ%. 
Thus, mcr-1-mediated resistance is not exclusive to humans and farm animals but also occurs in pet 
animals. Our study also extends the number of provinces and municipal cities, including Xinjiang, Hainan 
and Heilongjiang, in China where mcr-1 dissemination has been reported. Our study highlights the 
importance of active surveillance in relation to the nationwide and global spread of mcr-1. Finally, to 
facilitate a more holistic surveillance strategy, the PCR detection method that was developed as part of 
this study should be employed to test for the presence of mcr-1in both isolates and faecal samples. 
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Figure 1 
 
 
 
 
Screening and detection of the mcr-1 gene across China. Provinces/municipal cities where mcr-
1 screening was carried out and mcr-1-positive isolates were detected in this study. The areas in colour: 
provinces/municipal cities where isolates and/or faecal samples were collected. Pink: only isolates; 
yellow: isolates and faecal samples. Spots in colour represent areas where mcr-1-positive samples were 
isolated or detected. Blue spots: non-pathogenic E. coli strains; red spots: EPEC strains; yellow spots: 
EAEC strains; green spots: faecal samples. Grey bar represents mcr-1 screening area previously 
described by Liu et al. 
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Table 1 
Source and species of isolates used in this mcr-1 screening study 
 
pecies of isolates 
Origin of isolates 
No. of 
isolates 
Livestock 
faeces 
Poultry 
faeces 
Human 
faeces 
Food Other 
animals 
Environment 
Acinetobacter spp. 0 0 104 0 0 0 104 
Citrobacter spp. 0 0 11 0 0 0 11 
E. coli 
 
1709 
 Non-pathogenic E. coli 147 373 168 0 0 9 697 
 Pathogenic E. coli* 238 34 561 103 76 0 1012 
Enterobacter spp. 0 0 89 0 0 0 89 
Klebsiella spp. 0 110 152 0 0 0 262 
Proteus spp. 0 79 7 0 0 0 86 
Pseudomonas spp. 0 0 15 0 0 0 15 
Serratia spp. 0 0 26 0 0 0 26 
Other isolate species 0 0 28 0 0 0 28 
Total number 385 596 1161 103 76 9 2330 
 
 
*Pathogenic E. coli contained 325 E. coli O157 : H7 isolates, 157 diffusely adherent E. coli (DAEC) isolates, 128 enteroadherent E. 
coli (EAEC) isolates and 402 enteropathogenic E. coli (EPEC) isolates. 
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Table 2 
Description of isolates in the mcr-1 gene screening study 
 
 
 
Area of 
collection 
 
 
 
Year of 
collection 
 
Origin of isolates 
 
 
 
 
Total 
number of 
isolates 
 
Livestock  
faeces 
 
Poultry  
faeces 
 
Human 
faeces 
 
Food 
 
Insect 
 
Fowl 
faeces 
Rodent 
intestinal 
contents 
 
Environment 
Anhui 1999–2014 19 8 23 –* – – – – 50 
Beijing 2011–2014 – – 327 30 – 1 – – 358 
Gansu 2015 – – 44 – – – – – 44 
Guangdong 2013–2014 – – 103 – – – – – 103 
Guizhou 2011–2012 – – 3 – – – – – 3 
Hainan 2011–2015 – – 129 – – – – – 129 
Hebei 2005, 2011 – – 64 5 – – – – 69 
Heilongjiang 2009, 2012 3 – – – – – – – 3 
Henan 2000–2015 61 – 363 6 1 – – – 431 
Hubei 2006, 2011 – – 20 2 – – – – 22 
Jiangsu 1999–2002 139 25 16 1 4 – – – 185 
Ningxia 1998 2 – – – – – – – 2 
Qinghai 2012–2015 – – 6 – – – 54 – 60 
Shandong 2012–2013 5 563 4 – – – – – 572 
Shanghai 2013 – – 2 – – – – – 2 
Shanxi 2010 – – 22 – – – – – 22 
Sichuan 2012–2015 1 – 34 42 – 16 – – 93 
Tianjin 2001 5 – – – – – – – 5 
Xinjiang 2010–2013 147 – – – – – – 9 156 
Yunnan 2001 3 – 1 17 – – – – 21 
Total 1998–2009 230 33 17 31 5 – – – 316 
2010–2015 155 563 1144 72 – 17 54 9 2014 
1998–2015 385 596 1161 103 5 17 54 9 2330 
 
  *No isolates or no faecal samples were collected.  
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  Table 3 
  Description of mcr-1-positive isolates in this study 
 
Area of  
collection 
 
Year of  
collection 
 
Species of positive  
isolates 
 
No. of 
positive 
isolates 
 
Origin of isolates 
Anhui 2014 EPEC 1 Diarrhoea patient's faeces 
Beijing 2014 EPEC 2 Commercially available chicken and minced beef 
Guangdong 2014 EPEC 1 Healthy human faeces 
Henan 2011 EAEC 1 Diarrhoea patient's faeces 
Heilongjiang 2012 EPEC 2 Cattle faeces 
Shandong 2013 Nonpathogenic E. coli 12 Broiler faeces 
Sichuan 2014 EPEC 1 Broiler faeces 
2014 EPEC 2 Commercially available pork and chicken 
Xinjiang 2010–2013 Nonpathogenic E. coli 30 Broiler faeces 
2013 Nonpathogenic E. coli 2 Fence and water in swine farm 
Total number 54  
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  Table 4 
  Description of mcr-1-positive faecal samples in this study 
 
 
 
Area of collection 
 
Year of collection 
 
No. of positive samples 
 
Origin of faecal 
samples 
Beijing 2015 0 Human 
Beijing 2015 8 Pets 
Hainan 2014 6 Human 
Total number  14  
 
